James E. Crowe

37.9k total citations · 8 hit papers
417 papers, 19.2k citations indexed

About

James E. Crowe is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, James E. Crowe has authored 417 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Epidemiology, 192 papers in Infectious Diseases and 96 papers in Immunology. Recurrent topics in James E. Crowe's work include Respiratory viral infections research (127 papers), Viral Infections and Vectors (82 papers) and Viral gastroenteritis research and epidemiology (73 papers). James E. Crowe is often cited by papers focused on Respiratory viral infections research (127 papers), Viral Infections and Vectors (82 papers) and Viral gastroenteritis research and epidemiology (73 papers). James E. Crowe collaborates with scholars based in United States, France and Germany. James E. Crowe's co-authors include John V. Williams, Michael Diamond, Brian R. Murphy, Jens C. Krause, Kathryn M. Edwards, Ian A. Wilson, Nurgun Kose, Peter F. Wright, Sharon J. Tollefson and Scott A. Smith and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

James E. Crowe

403 papers receiving 18.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children

2004 703 citations James E. Crowe et al. profile →
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Rachel S. Nargi, Rachel E. Sutton et al. profile →
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

2010 485 citations Rui Xu, Damian C. Ekiert et al. Science profile →
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

2022 423 citations James E. Crowe, Michael Diamond et al. profile →
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

2016 295 citations Gopal Sapparapu, Nurgun Kose et al. profile →
Mxra8 is a receptor for multiple arthritogenic alphaviruses

2018 265 citations Julie M. Fox, James E. Crowe et al. profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Rachel S. Nargi et al. profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Rachel E. Sutton, Robert H. Carnahan et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
James E. Crowe	9.6k	9.0k	3.9k	3.8k	3.2k	417	19.2k
Barney S. Graham	15.6k 1.6×	13.9k 1.5×	5.9k 1.5×	7.2k 1.9×	1.8k 0.5×	359	30.9k
Florian Krammer	11.0k 1.1×	11.9k 1.3×	4.5k 1.2×	6.9k 1.8×	1.2k 0.4×	368	22.9k
Kanta Subbarao	14.8k 1.5×	15.3k 1.7×	4.1k 1.1×	5.9k 1.5×	1.1k 0.3×	305	27.4k
Vincent J. Munster	14.9k 1.6×	10.2k 1.1×	2.5k 0.6×	2.2k 0.6×	1.4k 0.4×	219	23.0k
Guus F. Rimmelzwaan	9.0k 0.9×	19.6k 2.2×	4.2k 1.1×	7.8k 2.0×	1.2k 0.4×	339	25.9k
Richard W. Compans	7.1k 0.7×	12.0k 1.3×	7.4k 1.9×	7.8k 2.0×	1.8k 0.5×	469	26.7k
Terrence M. Tumpey	6.7k 0.7×	17.9k 2.0×	4.0k 1.0×	8.3k 2.2×	967 0.3×	275	23.2k
Kwok‐Hung Chan	15.8k 1.6×	6.0k 0.7×	2.0k 0.5×	1.8k 0.5×	1.3k 0.4×	223	23.0k
Richard J. Webby	9.3k 1.0×	18.1k 2.0×	4.4k 1.1×	6.0k 1.6×	981 0.3×	507	25.3k
Lin‐Fa Wang	18.6k 1.9×	9.3k 1.0×	3.8k 1.0×	2.6k 0.7×	3.4k 1.1×	456	26.4k

Countries citing papers authored by James E. Crowe

Since Specialization

Citations

This map shows the geographic impact of James E. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Crowe more than expected).

Fields of papers citing papers by James E. Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Crowe. The network helps show where James E. Crowe may publish in the future.

Co-authorship network of co-authors of James E. Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Crowe. A scholar is included among the top collaborators of James E. Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Crowe. James E. Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Subramani, Chandru, Michelle Meyer, Haiping Hao, et al.. (2025). Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. Journal of Clinical Investigation. 135(17).

Meyer, Michelle, Bronwyn M. Gunn, Colette Pietzsch, et al.. (2025). Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Nature Communications. 16(1). 5702–5702. 1 indexed citations

Nkolola, Joseph P., David Hope, Malika Aïd, et al.. (2024). Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques. Journal of Virology. 98(12). e0142924–e0142924.

McMillen, Cynthia M., et al.. (2024). Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis. JCI Insight. 9(18). 1 indexed citations

Crowe, James E., et al.. (2023). Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody. Nature Microbiology. 8(7). 1293–1303. 9 indexed citations

Skinner, Nicole, Srinivasan Yegnasubramanian, Kornel E. Schuebel, et al.. (2023). Convergent antibody responses are associated with broad neutralization of hepatitis C virus. Frontiers in Immunology. 14. 1135841–1135841. 6 indexed citations

Skinner, Nicole, Andrew I. Flyak, Pamela J. Björkman, et al.. (2022). B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathogens. 18(1). e1010179–e1010179. 6 indexed citations

Crowe, James E., et al.. (2022). Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods. PLoS Computational Biology. 18(12). e1010230–e1010230. 2 indexed citations

Shiakolas, Andrea R., Kevin J. Kramer, Nicole V. Johnson, et al.. (2022). Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking. Nature Biotechnology. 40(8). 1270–1275. 27 indexed citations

10.

Crowe, James E., et al.. (2022). The human antibody sequence space and structural design of the V, J regions, and CDRH3 with Rosetta. mAbs. 14(1). 2068212–2068212. 4 indexed citations

11.

Schoeder, Clara T., et al.. (2021). RosettaCM for antibodies with very long HCDR3s and low template availability. Proteins Structure Function and Bioinformatics. 89(11). 1458–1472. 2 indexed citations

12.

Soto, Cinque, et al.. (2020). Human-likeness of antibody biologics determined by back-translation and comparison with large antibody variable gene repertoires. mAbs. 12(1). 1758291–1758291. 11 indexed citations

13.

Finn, Jessica A., Jinhui Dong, Alexander M. Sevy, et al.. (2020). Identification of Structurally Related Antibodies in Antibody Sequence Databases Using Rosetta-Derived Position-Specific Scoring. Structure. 28(10). 1124–1130.e5. 9 indexed citations

14.

Fox, Julie M., Ling Huang, Stephen Tahan, et al.. (2020). A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice. PLoS Pathogens. 16(8). e1008743–e1008743. 16 indexed citations

15.

Massaccesi, Guido, Andrew I. Flyak, Madeleine C. Mankowski, et al.. (2019). Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. Journal of Clinical Investigation. 129(11). 4786–4796. 36 indexed citations

16.

Messer, William B., Boyd L. Yount, Scott R. Royal, et al.. (2016). Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. Journal of Virology. 90(10). 5090–5097. 26 indexed citations

17.

Wec, Anna Z., Elisabeth K. Nyakatura, Andrew S. Herbert, et al.. (2016). A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses. Science. 354(6310). 350–354. 80 indexed citations

18.

Nivarthi, Usha K., Nurgun Kose, Gopal Sapparapu, et al.. (2016). Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination. Journal of Virology. 91(5). 39 indexed citations

19.

Fibriansah, G., Kristie D. Ibarra, Thiam‐Seng Ng, et al.. (2015). Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science. 349(6243). 88–91. 176 indexed citations

20.

Xu, Rui, Damian C. Ekiert, Jens C. Krause, et al.. (2010). Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus. Science. 328(5976). 357–360. 485 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact